ClinicalTrials.gg
RecruitingNCT07324863Updated Jan 8, 2026

Ultrasound Guided External Oblique and Rectus Abdominis Plane Block (EXORA) on Neuroendocrine Stress Response in Adults Undergoing Umbilical Hernia Surgery

An interventional study of General anesthesia and External oblique and rectus abdominis plane (EXORA) block in Ultrasound, External Oblique and Rectus Abdominis Plane Block, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2025, registered Dec 2025).
  • Started Aug 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
All
01

Study summary

This study aims to evaluate the efficacy of ultrasound-guided external oblique and rectus abdominis plane block on the neuroendocrine stress response and postoperative analgesia in adults undergoing umbilical hernia repair.

Read the detailed description

Umbilical hernias of the abdomen are defined as a non-inguinal, non-hiatal defect in the fascia of the abdominal wall. Surgical stress response refers to the physiologic response to surgery and the hormonal and metabolic changes that follow it.

Fascial plane blocks are gaining attention for perioperative analgesia due to their efficacy and safety profiles. The external oblique and rectus abdominis plane (EXORA) block is an emerging technique that provides a sensory block to the anterolateral abdominal wall, potentially filling gaps left by other commonly used blocks, such as the quadratus lumborum (QLB) or erector spinae plane (ESP) blocks.

02

Conditions studied

  • Ultrasound
  • External Oblique
  • Rectus Abdominis Plane Block
  • Neuroendocrine Stress Response
  • Umbilical Hernia

Browse trials for

03

In context

Hernia, Umbilical

67 studies on the registry are indexed under Hernia, Umbilical; 13 are open to participants now.

This study's planned enrollment of 100 is above the median of 66 across 40 interventional studies indexed under Hernia, Umbilical.

Browse Hernia, Umbilical studies →

Lead sponsor

Tanta University is the lead sponsor of 1,010 studies on the registry; 321 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged from 21 to 65 years.
  • Both sexes.
  • (ASA) Physical status I and Ⅱ.
  • Schedule for elective umbilical hernia surgery under general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • ASA Ⅲ or Ⅳ.
  • Patients with metabolic abnormalities, e.g., diabetes mellitus.
  • Patients receiving .
  • History of allergies to local anesthetics.
  • Bleeding or coagulation disorders.
  • Anatomical abnormalities.
  • Psychiatric and neurological disorders.
  • Complicated hernial defect (obstructed).
  • Patient refusal.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Group I

    Patients will receive general anesthesia only.

    Other: General anesthesia

  • Experimental
    Group Ⅱ

    Patients will receive general anesthesia and an external oblique and rectus abdominis plane (EXORA) block with 0.25% bupivacaine.

    Other: External oblique and rectus abdominis plane (EXORA) block

Interventions

  • OtherGeneral anesthesia

    Patients will receive general anesthesia only.

  • OtherExternal oblique and rectus abdominis plane (EXORA) block

    Patients will receive general anesthesia and an external oblique and rectus abdominis plane (EXORA) block with 0.25% bupivacaine.

06

What researchers measure

Primary outcomes

  1. Neuroendocrine stress response

    Neuroendocrine stress response will be measured by blood glucose level in adults undergoing umbilical hernia repair.

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Serum cortisol level

    Serum cortisol level will be measured.

    Time frame: 24 hours postoperatively

  2. Time of first rescue analgesia

    Time of first rescue analgesia will be recorded from the end of surgery till first dose of morphine administration.

    Time frame: 24 hours postoperatively

  3. Total intraoperative fentanyl consumption

    Rescue dose of intraoperative fentanyl given will be recorded.

    Time frame: Intraoperatively

  4. Total morphine consumption

    Intravenous morphine (rescue analgesic) at a dosage of 3 mg will be administered when the Numerical Rating Scale (NRS) score will be ≥ 4. The total morphine consumption over a 24-hours period will be recorded for these individuals.

    Time frame: 24 hours postoperatively

  5. Degree of pain

    Each patient will be instructed in postoperative pain assessment using the Numerical Rating Scale (NRS), ranging from 0 to 10 (0 = "no pain," 10 = "the worst pain imaginable"). NRS will be assessed at post-anesthesia care unit (PACU),1,2,4,6,12,24 hours postoperative

    Time frame: 24 hours postoperatively

07

Study locations

1 of 1 sites recruiting
  • Tanta University
    Tanta, 31527, Egypt
    Recruiting
    • Mayada H Sokeer, Master · Contactmayada.hady@med.tanta.edu.eg · 00201095315597
    • Lobna M Khalil, MD · Sub investigator
    • Gehan M Morsy, MD · Sub investigator
    • Alaa M Abo Hagar, MD · Sub investigator
    • Nashwa E Hamoda, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07324863
Lead sponsor
Tanta University
Responsible party
Mayada Hady Mahmoud Sokeer (Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Tanta University, Tanta, Egypt., Tanta University) — Principal investigator
First posted
Jan 8, 2026
Start date
Aug 1, 2025
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Jan 8, 2026

Study contacts

Mayada H Sokeer, Master
Contact
mayada.hady@med.tanta.edu.eg
00201095315597

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion